7Baggers
 immix biopharma — nexicart-2 enrolment progressing well  Smartkarma Fri, 19 Sep 2025 10:23:30 GMT
 immix biopharma surpasses 50% enrollment milestone in al amyloidosis trial  Investing.com India Fri, 19 Sep 2025 02:08:57 GMT
 Hunton Represents Goose Capital in Immix Biopharma Investment  Hunton Andrews Kurth LLP Thu, 18 Sep 2025 07:00:00 GMT
 immix biopharma, inc. (nasdaq:immx) short interest update  MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 00:57:12  newser.com Sun, 14 Sep 2025 05:57:12 GMT
 published on: 2025-09-13 10:44:57  newser.com Sat, 13 Sep 2025 15:44:57 GMT
 immix biopharma to present at the stifel 2025 healthcare conference  Investing News Network Fri, 12 Sep 2025 02:34:15 GMT
 immix biopharma receives strategic investment from goose capital by investing.com  Investing.com Australia Tue, 09 Sep 2025 11:26:46 GMT
 immix biopharma gets strategic investment  MarketScreener Mon, 08 Sep 2025 20:54:10 GMT
 published on: 2025-09-08 09:02:45  Newser Mon, 08 Sep 2025 14:02:45 GMT
 Immix Biopharma Announces Strategic Investment by Houston  GlobeNewswire Mon, 08 Sep 2025 07:00:00 GMT
 immix biopharma completes private placement transaction  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 oklahoma city news - the oklahoman  FinancialContent Mon, 08 Sep 2025 07:00:00 GMT
 Discover Immix Biopharma And 2 Other Promising Penny Stocks  simplywall.st Thu, 04 Sep 2025 07:00:00 GMT

Immix Biopharma
(NASDAQ:IMMX) 

IMMX stock logo

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. It is developing IMX-110 that is in Phase Ib/IIa clinical trials for the treatment of soft tissue sarcoma and...

Founded: 2012
IPO Price: $5 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends